Report for Cummings J

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (14)

Title : Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's disease - Bateman_2022_Alzheimers.Res.Ther_14_178
Author(s) : Bateman RJ , Cummings J , Schobel S , Salloway S , Vellas B , Boada M , Black SE , Blennow K , Fontoura P , Klein G , Assuncao SS , Smith J , Doody RS
Ref : Alzheimers Res Ther , 14 :178 , 2022
Abstract : Bateman_2022_Alzheimers.Res.Ther_14_178
ESTHER : Bateman_2022_Alzheimers.Res.Ther_14_178
PubMedSearch : Bateman_2022_Alzheimers.Res.Ther_14_178
PubMedID: 36447240

Title : Randomized, controlled, proof-of-concept trial of MK-7622 in Alzheimer's disease - Voss_2018_Alzheimers.Dement.(N.Y)_4_173
Author(s) : Voss T , Li J , Cummings J , Farlow M , Assaid C , Froman S , Leibensperger H , Snow-Adami L , McMahon KB , Egan M , Michelson D
Ref : Alzheimers Dement (N Y) , 4 :173 , 2018
Abstract : Voss_2018_Alzheimers.Dement.(N.Y)_4_173
ESTHER : Voss_2018_Alzheimers.Dement.(N.Y)_4_173
PubMedSearch : Voss_2018_Alzheimers.Dement.(N.Y)_4_173
PubMedID: 29955661

Title : Effects of Risperidone and Galantamine Treatment on Alzheimer's Disease Biomarker Levels in Cerebrospinal Fluid - Bloniecki_2017_J.Alzheimers.Dis_57_387
Author(s) : Bloniecki V , Aarsland D , Blennow K , Cummings J , Falahati F , Winblad B , Freund-Levi Y
Ref : J Alzheimers Dis , 57 :387 , 2017
Abstract : Bloniecki_2017_J.Alzheimers.Dis_57_387
ESTHER : Bloniecki_2017_J.Alzheimers.Dis_57_387
PubMedSearch : Bloniecki_2017_J.Alzheimers.Dis_57_387
PubMedID: 28269767

Title : ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials - Wang_2016_J.Neurol.Neurosurg.Psychiatry_87_993
Author(s) : Wang J , Logovinsky V , Hendrix SB , Stanworth SH , Perdomo C , Xu L , Dhadda S , Do I , Rabe M , Luthman J , Cummings J , Satlin A
Ref : Journal of Neurology Neurosurg Psychiatry , 87 :993 , 2016
Abstract : Wang_2016_J.Neurol.Neurosurg.Psychiatry_87_993
ESTHER : Wang_2016_J.Neurol.Neurosurg.Psychiatry_87_993
PubMedSearch : Wang_2016_J.Neurol.Neurosurg.Psychiatry_87_993
PubMedID: 27010616

Title : Role of Donepezil in the Management of Neuropsychiatric Symptoms in Alzheimer's Disease and Dementia with Lewy Bodies - Cummings_2016_CNS.Neurosci.Ther_22_159
Author(s) : Cummings J , Lai TJ , Hemrungrojn S , Mohandas E , Yun Kim S , Nair G , Dash A
Ref : CNS Neurosci Ther , 22 :159 , 2016
Abstract : Cummings_2016_CNS.Neurosci.Ther_22_159
ESTHER : Cummings_2016_CNS.Neurosci.Ther_22_159
PubMedSearch : Cummings_2016_CNS.Neurosci.Ther_22_159
PubMedID: 26778658

Title : Evaluating the cognitive effects of donepezil 23 mg\/d in moderate and severe Alzheimer's disease: analysis of effects of baseline features on treatment response - Sabbagh_2013_BMC.Geriatr_13_56
Author(s) : Sabbagh M , Cummings J , Christensen D , Doody R , Farlow M , Liu L , Mackell J , Fain R
Ref : BMC Geriatr , 13 :56 , 2013
Abstract : Sabbagh_2013_BMC.Geriatr_13_56
ESTHER : Sabbagh_2013_BMC.Geriatr_13_56
PubMedSearch : Sabbagh_2013_BMC.Geriatr_13_56
PubMedID: 23742728

Title : Symptomatic and nonamyloid\/tau based pharmacologic treatment for Alzheimer disease - Aisen_2012_Cold.Spring.Harb.Perspect.Med_2_a006395
Author(s) : Aisen PS , Cummings J , Schneider LS
Ref : Cold Spring Harb Perspect Med , 2 :a006395 , 2012
Abstract : Aisen_2012_Cold.Spring.Harb.Perspect.Med_2_a006395
ESTHER : Aisen_2012_Cold.Spring.Harb.Perspect.Med_2_a006395
PubMedSearch : Aisen_2012_Cold.Spring.Harb.Perspect.Med_2_a006395
PubMedID: 22393531

Title : Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology - Sabbagh_2011_BMC.Neurol_11_21
Author(s) : Sabbagh M , Cummings J
Ref : BMC Neurol , 11 :21 , 2011
Abstract : Sabbagh_2011_BMC.Neurol_11_21
ESTHER : Sabbagh_2011_BMC.Neurol_11_21
PubMedSearch : Sabbagh_2011_BMC.Neurol_11_21
PubMedID: 21299848

Title : Management of behavioral problems in Alzheimer's disease - Gauthier_2010_Int.Psychogeriatr_22_346
Author(s) : Gauthier S , Cummings J , Ballard C , Brodaty H , Grossberg G , Robert P , Lyketsos C
Ref : Int Psychogeriatr , 22 :346 , 2010
Abstract : Gauthier_2010_Int.Psychogeriatr_22_346
ESTHER : Gauthier_2010_Int.Psychogeriatr_22_346
PubMedSearch : Gauthier_2010_Int.Psychogeriatr_22_346
PubMedID: 20096151

Title : Quetiapine for agitation or psychosis in patients with dementia and parkinsonism - Kurlan_2007_Neurology_68_1356
Author(s) : Kurlan R , Cummings J , Raman R , Thal L
Ref : Neurology , 68 :1356 , 2007
Abstract : Kurlan_2007_Neurology_68_1356
ESTHER : Kurlan_2007_Neurology_68_1356
PubMedSearch : Kurlan_2007_Neurology_68_1356
PubMedID: 17452579

Title : Pharmacokinetic rationale for the rivastigmine patch - Cummings_2007_Neurology_69_S10
Author(s) : Cummings J , Lefevre G , Small G , Appel-Dingemanse S
Ref : Neurology , 69 :S10 , 2007
Abstract : Cummings_2007_Neurology_69_S10
ESTHER : Cummings_2007_Neurology_69_S10
PubMedSearch : Cummings_2007_Neurology_69_S10
PubMedID: 17646618

Title : Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium - McKeith_2005_Neurology_65_1863
Author(s) : McKeith IG , Dickson DW , Lowe J , Emre M , O'Brien JT , Feldman H , Cummings J , Duda JE , Lippa C , Perry EK , Aarsland D , Arai H , Ballard CG , Boeve B , Burn DJ , Costa D , Del Ser T , Dubois B , Galasko D , Gauthier S , Goetz CG , Gomez-Tortosa E , Halliday G , Hansen LA , Hardy J , Iwatsubo T , Kalaria RN , Kaufer D , Kenny RA , Korczyn A , Kosaka K , Lee VM , Lees A , Litvan I , Londos E , Lopez OL , Minoshima S , Mizuno Y , Molina JA , Mukaetova-Ladinska EB , Pasquier F , Perry RH , Schulz JB , Trojanowski JQ , Yamada M
Ref : Neurology , 65 :1863 , 2005
Abstract : McKeith_2005_Neurology_65_1863
ESTHER : McKeith_2005_Neurology_65_1863
PubMedSearch : McKeith_2005_Neurology_65_1863
PubMedID: 16237129

Title : Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II--Pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council - Fillit_2000_Manag.Care.Interface_13_51
Author(s) : Fillit H , Cummings J
Ref : Manag Care Interface , 13 :51 , 2000
Abstract : Fillit_2000_Manag.Care.Interface_13_51
ESTHER : Fillit_2000_Manag.Care.Interface_13_51
PubMedSearch : Fillit_2000_Manag.Care.Interface_13_51
PubMedID: 10747691

Title : Opportunities for improving managed care for individuals with dementia: Part 1--The issues - Fillit_1999_Am.J.Manag.Care_5_309
Author(s) : Fillit H , Knopman D , Cummings J , Appel F
Ref : Am J Manag Care , 5 :309 , 1999
Abstract : Fillit_1999_Am.J.Manag.Care_5_309
ESTHER : Fillit_1999_Am.J.Manag.Care_5_309
PubMedSearch : Fillit_1999_Am.J.Manag.Care_5_309
PubMedID: 10351027